n-phenyl-1h-1,2,4-triazole-3,5-diamine has been researched along with Metastase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fearnley, GW; Fishwick, CW; Gage, MC; Homer-Vanniasinkam, S; Kankanala, J; Kearney, MT; Latham, AM; Ponnambalam, S; Wheatcroft, SB | 1 |
1 other study(ies) available for n-phenyl-1h-1,2,4-triazole-3,5-diamine and Metastase
Article | Year |
---|---|
In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis.
Topics: Angiogenesis Inhibitors; Aniline Compounds; Animals; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Design; Endothelial Cells; Female; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Neovascularization, Physiologic; Protein Kinase Inhibitors; Signal Transduction; Triazoles; Vascular Endothelial Growth Factor Receptor-2; Wound Healing | 2014 |